Title: William D. Martin: Innovator in Influenza Vaccine Development
Introduction
William D. Martin is a notable inventor in the field of vaccine development, particularly focusing on influenza. He is based in the United States and has made significant contributions to the understanding and modification of hemagglutinin glycoproteins.
Latest Patents
William D. Martin holds a patent titled "Modified H7 Hemagglutinin Glycoprotein Of The Influenza A/Shanghai/2/2013 H7 Sequence." The abstract of this patent describes a sequence modification of the H7 hemagglutinin glycoprotein, along with vaccines derived from this modification. The invention also includes methods for improving the efficacy of vaccine antigens by modifying T cell epitopes. Despite his innovative work, he currently has 0 patents registered.
Career Highlights
William D. Martin is associated with Epivax, Inc., a company that specializes in vaccine development and immunotherapy. His work at Epivax has been instrumental in advancing the field of influenza vaccines.
Collaborations
William collaborates with Anne Searls De Groot, who is also involved in vaccine research and development. Their partnership contributes to the innovative approaches taken at Epivax.
Conclusion
William D. Martin is a key figure in the development of influenza vaccines, focusing on innovative modifications to hemagglutinin glycoproteins. His work continues to influence the field of immunology and vaccine efficacy.